<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:50:55 -0700</creation_date>
  <update_date>2013-05-27 11:29:46 -0600</update_date>
  <accession>HMDBP00617</accession>
  <secondary_accessions>
    <accession>5889</accession>
    <accession>HMDBP04371</accession>
  </secondary_accessions>
  <protein_type>Unknown</protein_type>
  <synonyms>
    <synonym>CGS-PDE</synonym>
    <synonym>Cyclic GMP-stimulated phosphodiesterase</synonym>
    <synonym>cGSPDE</synonym>
  </synonyms>
  <gene_name>PDE2A</gene_name>
  <general_function>Involved in catalytic activity</general_function>
  <specific_function>Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes.
</specific_function>
  <pathways>
    <pathway>
      <name>Purine metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00230</kegg_map_id>
    </pathway>
    <pathway>
      <name>Morphine addiction</name>
      <smpdb_id/>
      <kegg_map_id>map05032</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00058</accession>
      <name>Cyclic AMP</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00045</accession>
      <name>Adenosine monophosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01314</accession>
      <name>Cyclic GMP</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01397</accession>
      <name>Guanosine monophosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02111</accession>
      <name>Water</name>
    </metabolite>
    <metabolite>
      <accession>HMDB05039</accession>
      <name>Sildenafil</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15699</accession>
      <name>Tofisopam</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity, acting on ester bonds</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>phosphoric ester hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>phosphoric diester hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>cyclic-nucleotide phosphodiesterase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>3',5'-cyclic-nucleotide phosphodiesterase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>biological regulation</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>regulation of biological process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>regulation of cellular process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>signal transduction</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytosol</description>
      <go_id>GO:0005829</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>endoplasmic reticulum</description>
      <go_id>GO:0005783</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>Golgi apparatus</description>
      <go_id>GO:0005794</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>membrane raft</description>
      <go_id>GO:0045121</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>mitochondrial matrix</description>
      <go_id>GO:0005759</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>nucleus</description>
      <go_id>GO:0005634</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>perinuclear region of cytoplasm</description>
      <go_id>GO:0048471</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>plasma membrane</description>
      <go_id>GO:0005886</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>presynaptic membrane</description>
      <go_id>GO:0042734</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>calcium channel activity</description>
      <go_id>GO:0005262</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>cAMP binding</description>
      <go_id>GO:0030552</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>cGMP binding</description>
      <go_id>GO:0030553</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>cGMP-stimulated cyclic-nucleotide phosphodiesterase activity</description>
      <go_id>GO:0004118</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>drug binding</description>
      <go_id>GO:0008144</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>metal ion binding</description>
      <go_id>GO:0046872</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>blood coagulation</description>
      <go_id>GO:0007596</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cAMP catabolic process</description>
      <go_id>GO:0006198</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cAMP-mediated signaling</description>
      <go_id>GO:0019933</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to cGMP</description>
      <go_id>GO:0071321</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to drug</description>
      <go_id>GO:0035690</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to granulocyte macrophage colony-stimulating factor stimulus</description>
      <go_id>GO:0097011</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to macrophage colony-stimulating factor stimulus</description>
      <go_id>GO:0036006</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to mechanical stimulus</description>
      <go_id>GO:0071260</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to transforming growth factor beta stimulus</description>
      <go_id>GO:0071560</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cGMP catabolic process</description>
      <go_id>GO:0046069</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cGMP-mediated signaling</description>
      <go_id>GO:0019934</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>establishment of endothelial barrier</description>
      <go_id>GO:0061028</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>monocyte differentiation</description>
      <go_id>GO:0030224</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of cAMP biosynthetic process</description>
      <go_id>GO:0030818</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of protein import into nucleus, translocation</description>
      <go_id>GO:0033159</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of transcription from RNA polymerase II promoter</description>
      <go_id>GO:0000122</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of vascular permeability</description>
      <go_id>GO:0043116</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>positive regulation of inflammatory response</description>
      <go_id>GO:0050729</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>positive regulation of vascular permeability</description>
      <go_id>GO:0043117</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>protein targeting to mitochondrion</description>
      <go_id>GO:0006626</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Membrane</subcellular_location>
    <subcellular_location>Peripheral membrane protein (Potential)</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>11</chromosome_location>
    <locus>11q13.4</locus>
    <gene_sequence>&gt;2826 bp
ATGGGGCAGGCATGCGGCCACTCCATCCTCTGCAGGAGCCAGCAGTACCCGGCAGCGCGA
CCGGCTGAGCCGCGGGGCCAGCAGGTCTTCCTCAAGCCGGACGAGCCGCCGCCGCCGCCG
CAGCCATGCGCCGACAGCCTGCAGGACGCCTTGCTGAGTCTGGGCTCTGTCATCGACATT
TCAGGCCTGCAACGTGCTGTCAAGGAGGCCCTGTCAGCTGTGCTCCCCCGAGTGGAAACT
GTCTACACCTACCTACTGGATGGTGAGTCCCAGCTGGTGTGTGAGGACCCCCCACATGAG
CTGCCCCAGGAGGGGAAAGTCCGGGAGGCTATCATCTCCCAGAAGCGGCTGGGCTGCAAT
GGGCTGGGCTTCTCAGACCTGCCAGGGAAGCCCTTGGCCAGGCTGGTGGCTCCACTGGCT
CCTGATACCCAAGTGCTGGTCATGCCGCTAGCGGACAAGGAGGCTGGGGCCGTGGCAGCT
GTCATCTTGGTGCACTGTGGCCAGCTGAGTGATAATGAGGAATGGAGCCTGCAGGCGGTG
GAGAAGCATACCCTGGTCGCCCTGCGGAGGGTGCAGGTCCTGCAGCAGCGCGGGCCCAGG
GAGGCTCCCCGAGCCGTCCAGAACCCCCCGGAGGGGACGGCGGAAGACCAGAAGGGCGGG
GCGGCGTACACCGACCGCGACCGCAAGATCCTCCAACTGTGCGGGGAACTCTACGACCTG
GATGCCTCTTCCCTGCAGCTCAAAGTGCTCCAATACCTGCAGCAGGAGACCCGGGCATCC
CGCTGCTGCCTCCTGCTGGTGTCGGAGGACAATCTCCAGCTTTCTTGCAAGGTCATCGGA
GACAAAGTGCTCGGGGAAGAGGTCAGCTTTCCCTTGACAGGATGCCTGGGCCAGGTGGTG
GAAGACAAGAAGTCCATCCAGCTGAAGGACCTCACCTCCGAGGATGTACAACAGCTGCAG
AGCATGTTGGGCTGTGAGCTGCAGGCCATGCTCTGTGTCCCTGTCATCAGCCGGGCCACT
GACCAGGTGGTGGCCTTGGCCTGCGCCTTCAACAAGCTAGAAGGAGACTTGTTCACCGAC
GAGGACGAGCATGTGATCCAGCACTGCTTCCACTACACCAGCACCGTGCTCACCAGCACC
CTGGCCTTCCAGAAGGAACAGAAACTCAAGTGTGAGTGCCAGGCTCTTCTCCAAGTGGCA
AAGAACCTCTTCACCCACCTGGATGACGTCTCTGTCCTGCTCCAGGAGATCATCACGGAG
GCCAGAAACCTCAGCAACGCAGAGATCTGCTCTGTGTTCCTGCTGGATCAGAATGAGCTG
GTGGCCAAGGTGTTCGACGGGGGCGTGGTGGATGATGAGAGCTATGAGATCCGCATCCCG
GCCGATCAGGGCATCGCGGGACACGTGGCGACCACGGGCCAGATCCTGAACATCCCTGAC
GCATATGCCCATCCGCTTTTCTACCGCGGCGTGGACGACAGCACCGGCTTCCGCACGCGC
AACATCCTCTGCTTCCCCATCAAGAACGAGAACCAGGAGGTCATCGGTGTGGCCGAGCTG
GTGAACAAGATCAATGGGCCATGGTTCAGCAAGTTCGACGAGGACCTGGCGACGGCCTTC
TCCATCTACTGCGGCATCAGCATCGCCCATTCTCTCCTATACAAAAAAGTGAATGAGGCT
CAGTATCGCAGCCACCTGGCCAATGAGATGATGATGTACCACATGAAGGTCTCCGACGAT
GAGTATACCAAACTTCTCCATGATGGGATCCAGCCTGTGGCTGCCATTGACTCCAATTTT
GCAAGTTTCACCTATACCCCTCGTTCCCTGCCCGAGGATGACACGTCCATGGCCATCCTG
AGCATGCTGCAGGACATGAATTTCATCAACAACTACAAAATTGACTGCCCGACCCTGGCC
CGGTTCTGTTTGATGGTGAAGAAGGGCTACCGGGATCCCCCCTACCACAACTGGATGCAC
GCCTTTTCTGTCTCCCACTTCTGCTACCTGCTCTACAAGAACCTGGAGCTCACCAACTAC
CTCGAGGACATCGAGATCTTTGCCTTGTTTATTTCCTGCATGTGTCATGACCTGGACCAC
AGAGGCACAAACAACTCTTTCCAGGTGGCCTCGAAATCTGTGCTGGCTGCGCTCTACAGC
TCTGAGGGCTCCGTCATGGAGAGGCACCACTTTGCTCAGGCCATCGCCATCCTCAACACC
CACGGCTGCAACATCTTTGATCATTTCTCCCGGAAGGACTATCAGCGCATGCTGGATCTG
ATGCGGGACATCATCTTGGCCACAGACCTGGCCCACCATCTCCGCATCTTCAAGGACCTC
CAGAAGATGGCTGAGGTGGGCTACGACCGAAACAACAAGCAGCACCACAGACTTCTCCTC
TGCCTCCTCATGACCTCCTGTGACCTCTCTGACCAGACCAAGGGCTGGAAGACTACGAGA
AAGATCGCGGAGCTGATCTACAAAGAATTCTTCTCCCAGGGAGACCTGGAGAAGGCCATG
GGCAACAGGCCGATGGAGATGATGGACCGGGAGAAGGCCTATATCCCTGAGCTGCAAATC
AGCTTCATGGAGCACATTGCAATGCCCATCTACAAGCTGTTGCAGGACCTGTTCCCCAAA
GCGGCAGAGCTGTACGAGCGCGTGGCCTCCAACCGTGAGCACTGGACCAAGGTGTCCCAC
AAGTTCACCATCCGCGGCCTCCCAAGTAACAACTCGCTGGACTTCCTGGATGAGGAGTAC
GAGGTGCCTGATCTGGATGGCACTAGGGCCCCCATCAATGGCTGCTGCAGCCTTGATGCT
GAGTGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>941</residue_number>
    <molecular_weight>105145.485</molecular_weight>
    <theoretical_pi>5.444</theoretical_pi>
    <pfams>
      <pfam>
        <name>GAF</name>
        <pfam_id>PF01590</pfam_id>
      </pfam>
      <pfam>
        <name>PDEase_I</name>
        <pfam_id>PF00233</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;cGMP-dependent 3',5'-cyclic phosphodiesterase
MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDI
SGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCN
GLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAV
EKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDL
DASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVV
EDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTD
EDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITE
ARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPD
AYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAF
SIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNF
ASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMH
AFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYS
SEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDL
QKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAM
GNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSH
KFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE</protein_sequence>
  </protein_properties>
  <genbank_protein_id>2108052</genbank_protein_id>
  <uniprot_id>O00408</uniprot_id>
  <uniprot_name>PDE2A_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1Z1L</pdb_id>
    <pdb_id>3IBJ</pdb_id>
    <pdb_id>3ITM</pdb_id>
    <pdb_id>3ITU</pdb_id>
  </pdb_ids>
  <genbank_gene_id>U67733</genbank_gene_id>
  <genecard_id>PDE2A</genecard_id>
  <geneatlas_id>PDE2A</geneatlas_id>
  <hgnc_id>HGNC:8777</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Rosman GJ, Martins TJ, Sonnenburg WK, Beavo JA, Ferguson K, Loughney K: Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase. Gene. 1997 May 20;191(1):89-95.</reference_text>
      <pubmed_id>9210593</pubmed_id>
    </reference>
    <reference>
      <reference_text>Oppermann FS, Gnad F, Olsen JV, Hornberger R, Greff Z, Keri G, Mann M, Daub H: Large-scale proteomics analysis of the human kinome.  Mol Cell Proteomics. 2009 Jul;8(7):1751-64. Epub 2009 Apr 15.</reference_text>
      <pubmed_id>19369195</pubmed_id>
    </reference>
    <reference>
      <reference_text>Iffland A, Kohls D, Low S, Luan J, Zhang Y, Kothe M, Cao Q, Kamath AV, Ding YH, Ellenberger T: Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system. Biochemistry. 2005 Jun 14;44(23):8312-25.</reference_text>
      <pubmed_id>15938621</pubmed_id>
    </reference>
    <reference>
      <reference_text>Pandit J, Forman MD, Fennell KF, Dillman KS, Menniti FS: Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct. Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18225-30. Epub 2009 Oct 14.</reference_text>
      <pubmed_id>19828435</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Tofisopam</name>
        <accession>HMDB15699</accession>
      </metabolite>
      <reference>
        <reference_text>Rundfeldt C, Socala K, Wlaz P: The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. J Neural Transm. 2010 Nov;117(11):1319-25. Epub 2010 Oct 22.</reference_text>
        <pubmed_id>20967473</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
